IL21 and neoplasm: Tumor infiltrating lymphocytes (TILs) cultivated in the presence of K562 artificial antigen-presenting cells engineered to secrete IL-21 exhibited a less-differentiated young phenotype and presented superior antitumor activity upon adoptive transfer, without collateral expansion of Tregs (78).